KURA: Kura Oncology, Inc. Stock

by  •  • Comments Off on KURA: Kura Oncology, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,568.56
Enterprise Value ($M) 1,540.57
Book Value ($M) 505.08
Book Value / Share 5.21
Price / Book 3.95
NCAV ($M) 380.82
NCAV / Share 5.00
Price / NCAV 4.12

Profitability (mra)
Return on Invested Capital (ROIC) -0.41
Return on Assets (ROA) -0.39
Return on Equity (ROE) -0.43

Liquidity (mrq)
Quick Ratio 12.26
Current Ratio 12.26

Balance Sheet (mrq) ($M)
Current Assets 537.84
Assets 553.91
Liabilities 48.82
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -165.80
Net Income -152.63
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -124.82
Cash from Investing 15.56
Cash from Financing 94.78

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
4 days ago 13G Paradigm Biocapital Advisors LP 5.10
02-14 13G/A EcoR1 Capital, LLC 9.99 14.47
02-14 13G/A Biotechnology Value Fund L P 9.90 93.98
02-13 13G/A Suvretta Capital Management, Llc 9.99 17.18
02-13 13G/A Vanguard Group Inc 5.44 18.58
02-12 13G/A Flynn James E 7.15 21.46
01-24 13G/A BlackRock Inc. 9.80 41.70
01-23 13G/A State Street Corp 3.93 -34.29

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 58,831 491,689 11.97
2024-05-02 78,074 294,560 26.51
2024-05-01 88,615 410,494 21.59
2024-04-30 79,643 249,678 31.90

(click for more detail)

Similar Companies
KPTI – Karyopharm Therapeutics Inc. KRON – Kronos Bio, Inc.
KRYS – Krystal Biotech, Inc. KYTX – Kyverna Therapeutics, Inc.
KZR – Kezar Life Sciences, Inc.


Financial data and stock pages provided by
Fintel.io